Accurate prediction of the outcome of acute stroke is important for several reasons. A reliable prognosis must be given to relatives and realistic rehabilitation goals must be set. Specialised resources should be allocated in the most efficient way, and stroke patients should be stratified into different prognostic groups for clinical trials.
Many clinical signs and other variables have been found to have prognostic importance, but since most of them are markers of overall stroke severity they tend to be strongly interrelated. Multivariate analysis has therefore been advocated to identify and bring together those factors that make an independent contribution to the prediction of outcome. Several models have been derived'`which combine variables into a discriminant function or multiple regression formula, but, as previously noted,6 the more complex these models become the less likely they are to be widely applicable. One such model,' for instance, makes use of a version of a mental test score7 which itself has been modified by means of multivariate analysis to maximise its discriminant power. As a result, some of the questions are negatively weighted so that patients who answer them correctly have a poorer predicted outcome than those who do not. These weightings may help the model to fit more closely the data from which it was derived, but they are unlikely to increase the true prognostic value of the overall score.
Multivariate models are also difficult to use in practice. They may require several minutes work with a pocket calculator, incorporating a range of disparate information, some of which may be based on rating scales of dubious reliability. To outweigh these disadvantages these models must therefore be shown to produce substantial improvements in predictive accuracy over simpler univariate methods.
We therefore chose to test prospectively the three prognostic models that had been developed for use in acute stroke in Belfast,' Guy ments were included in the analyses of outcome at later stages and were given a Barthel score of 0/20 for the analysis predicting good outcome.
Results
We studied 102 consecutive patients admitted with acute stroke over a three month period. The mean age was 75 (range 42-91) years, and 22 had suffered one or more strokes in the past. By the end of the first week, 13 patients (13%) had died and 19 (19%) had been discharged, leaving 70 patients (68%) still in hospital. At four weeks 23 patients (23%) had died, 38 (37%) had been discharged, and 41 (40%) remained in hospital, and by three months the equivalent figures were 33 patients (32%), 55 (54%), and 14 (14%).
Albert's line cancellation test could not be attempted at the first assessment by 45 patients (44%); they were assigned the average test score, which was 28-8 for our group, compared with 28-5 in the original Belfast study.' The Edinburgh score could not be calculated in two patients and we were unable to perform a Barthel activities of daily living assessment at three months in one patient. Table 2 shows the rank correlations between the predictive model scores, the conscious level and urinary continence, and the various measures of recovery. As expected the correlations were all highly significant (p < 0-001). Table 3 compares the accuracy of the Guy's, Uppsala, and Belfast models and of the admission conscious level (ACL) alone in predicting death within three months. The Belfast model was the most sensitive and least specific in predicting fatal outcome. The explanation can be seen in the right hand column, which shows that this model predicted an overall fatality rate of 78%, more than twice the actual rate. Conversely, the Uppsala model predicted a very low overall death rate and was correspondingly highly specific but insensitive. The overall accuracy and prognostic contribution 
Discussion
If they are to be widely applied predictive models should be derived from an unselected and representative series of patients. The patients in our study were admitted consecutively to a large district general hospital and should therefore be representative of the generality of patients admitted to hospital with acute stroke, the target population for most studies of outcome prediction. Other studies have been more selective: the Belfast workers excluded patients with previous mental and physical disability;' the Guy's study excluded all those over 75 years of age;2 the Uppsala model was designed for patients aged under 70 deemed to have had a first cerebral infarction;3 the Edinburgh score was derived from a selected "middle band" of patients participating in an evaluation of a stroke unit,4 and the Bristol score could be derived only retrospectively, after deaths had been excluded.5
The choice of the study population used when producing a multivariate model will also affect the factors selected by the modelling process and their relative weightings. For example, the Bristol score can predict a Barthel score of less than 10/20 at six months only if the patient has maximum impairment and is aged over 100 years. This model was derived from a selected group of patients who had a generally favourable outcome, and this largely explains its poor performance in our more heterogeneous study population.
Our findings have confirmed previous suggestions6 that complex models are likely to be much less accurate when used prospectively to make real predictions than when used retrospectively to fit previously collected data. The Belfast model was 83% accurate in "predicting" death or survival in the original report,' but its predictions were only 50% accurate in our series. Similarly, Wade et al claimed to (1-7 to 3 7)
Actual death rate 32%. "predict" the Barthel score at six months to within two points in 72% of cases,4 whereas we found the Bristol model could correctly predict a Barthel score above or below 10 in only 38% of cases. Admittedly we measured outcome at three months, as opposed to six months in the Belfast and Bristol studies, but this by no means explains the large discrepancy in the results. The Belfast model was inordinately pessimistic in our survey, predicting death in 78% of cases whereas the actual death rate was only 32%. Reducing the model's high sensitivity for fatal outcome might have improved its specificity and discriminatory power, but its complex design makes this difficult to do.
The Guy's and Uppsala models were less sensitive but more specific in their prediction of death than the conscious level alone and seemed to have greater overall accuracy. When the cutoff scores were adjusted to equalise the sensitivity, however, it became clear how little additional prognostic information these models contained. The Guy's score performed no better than ACL alone, whereas the Uppsala model produced only a modest increase in likelihood ratio. This might be of some use in stratifying patients for research studies, but the models' predictions are probably not accurate enough to be used as a basis for management decisions on individual patients. There would also seem to be little advantage in using these complex models when giving an approximate prognosis to relatives.
For predicting functional outcome at a later stage, urinary continence proved as accurate on its own as the Edinburgh score. This confirms that urinary continence is a simple yet useful predictor of outcome,2 13 and shows the lack of additional prognostic information contained in the Edinburgh model. This study has shown some of the limitations of multivariate linear models as predictive instruments in stroke. Even if their accuracy could be improved, they are unlikely to be able to cope with the diversity of patients found in everyday practice or be of much use in their management. Additional prognostic information may be obtained from CT scanning, though one study indicated that it did not add much to predictions based on clinical data alone.'4 An alternative approach, in which a quasi-anatomical classification is derived from the clinical signs, has recently been proposed '5 and initial results suggest that this may also be an efficient method of prognostic stratification. Further work along the lines presented here will be required to validate the classification prospectively in terms both of clinical-CT comparisons and of outcome predictions. We believe that greater flexibility and accuracy could be achieved by an algorithm, which could use different prognostic variables in different situations and could incorporate information on the rate of change of neurological and functional status. Such an algorithm would be based on a Bayesian model which could be continuously updated by new data, rather than the "closed" multiple regression models examined here. It could also be designed to guide clinical decisions, rather than merely make predictions of outcome of little practical value. Much work is required to develop this approach, but in the meantime simple clinical variables offer as much to the clinician as complex multivariate models in the prediction of outcome in stroke. 
